CoChat

Severity of disease and risk of malignant change in hereditary multiple exostoses: A GENOTYPE-PHENOTYPE STUDY

Open access
Porter, D. E., Lonie, L., Fraser, M., Dobson-Stone, C., Porter, J. R., Monaco, A. P., Simpson, A. H. R. W. · 2004 · The Journal of Bone and Joint Surgery. British volume
Cited by 218

The DOI matches its Crossref record.

Abstract

We performed a prospective genotype-phenotype study using molecular screening and clinical assessment to compare the severity of disease and the risk of sarcoma in 172 individuals (78 families) with hereditary multiple exostoses. We calculated the severity of disease including stature, number of exostoses, number of surgical procedures that were necessary, deformity and functional parameters and used molecular techniques to identify the genetic mutations in affected individuals. Each arm of the genotype-phenotype study was blind to the outcome of the other. Mutations EXT1 and EXT2 were almost equally common, and were identified in 83% of individuals. Non-parametric statistical tests were used. There was a wide variation in the severity of disease. Children under ten years of age had fewer exostoses, consistent with the known age-related penetrance of this condition. The severity of the disease did not differ significantly with gender and was very variable within any given family. The sites of mutation affected the severity of disease with patients with EXT1 mutations having a significantly worse condition than those with EXT2 mutations in three of five parameters of severity (stature, deformity and functional parameters). A single sarcoma developed in an EXT2 mutation carrier, compared with seven in EXT1 mutation carriers. There was no evidence that sarcomas arose more commonly in families in whom the disease was more severe. The sarcoma risk in EXT1 carriers is similar to the risk of breast cancer in an older population subjected to breast-screening, suggesting that a role for regular screening in patients with hereditary multiple exostoses is justifiable.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1302/0301-620x.86b7.14815

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

  • The exostosin glycosyltransferase 1/STAT3 axis is a driver of breast cancer aggressiveness

    Solaimuthu, B., Khatib, A., Tanna, M., Karmi, A., Hayashi, A., Abu Rmaileh, A., Lichtenstein, M., Takoe, S., Jolly, M. K., & Shaul, Y. D. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316733121 · Cited by 8

    “Finally, patients with EXT1 mutations and multiple osteochondromas are more prone to malignant transformation than those with EXT2 mutations (51, In study, genetic manipulation techniques established a clear correlation between EXT1 and cancer cell aggressiveness, which was inert for endogenous…”
    Background

See all 218

Metadata

Authors
Porter, D. E., Lonie, L., Fraser, M., Dobson-Stone, C., Porter, J. R., Monaco, A. P., & Simpson, A. H. R. W.
Venue
The Journal of Bone and Joint Surgery. British volume
Published
2004-09
Volume
86-B
Issue
7
Pages
1041-1046
ISSN
  • 0301-620X (ISSN-L)
  • 2044-5377
OpenAlex
W1982059998
Cited by
218
References
0
FWCI
3.13
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Severity of disease and risk of malignant change in hereditary multiple exostoses: A GENOTYPE-PHENOTYPE STUDY. https://app.cochat.ai/papers/10.1302/0301-620x.86b7.14815
The paper
Porter, D. E., Lonie, L., Fraser, M., Dobson-Stone, C., Porter, J. R., Monaco, A. P., & Simpson, A. H. R. W. (2004). Severity of disease and risk of malignant change in hereditary multiple exostoses: A GENOTYPE-PHENOTYPE STUDY. The Journal of Bone and Joint Surgery. British volume. https://doi.org/10.1302/0301-620x.86b7.14815

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.